Literature DB >> 17876878

Crohn's disease incidence evolution in North-western Greece is not associated with alteration of NOD2/CARD15 variants.

Michael Economou1, Grigoris Filis, Zoi Tsianou, John Alamanos, Antonios Kogevinas, Kostas Masalas, Anna Petrou, Epameinondas V Tsianos.   

Abstract

AIM: To assess the trends in the incidence of inflammatory bowel disease (IBD) over 23 years in the same area and to identify genetic factors related to incidence evolution.
METHODS: Patients with IBD arising from North-western Greece were systematically recorded through the 1983-2005 period. Trends in disease incidence and genetic patterns related to CARD15 variants were documented and correlated.
RESULTS: A total of 447 patients with IBD were recorded (23.5% Crohn's disease, 72.7% Ulcerative colitis and 3.8% indeterminate colitis). Mean annual incidence rates of CD and UC were 0.9/100,000 (95% CI 0.1-1.7) and 2.7/100,000 (95% CI 1.7-4.1) inhabitants, respectively. There was a statistically significant increase of CD incidence (P<0.01) during the study period, in contrast to the UC incidence. There were no statistical differences in CARD15 variants over the study period.
CONCLUSION: The incidence of CD in North-western Greece has risen disproportionately to that of UC in the 21st century. This is not related to alterations of genetic background though.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17876878      PMCID: PMC4434642          DOI: 10.3748/wjg.v13.i38.5116

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

Review 1.  New genes in inflammatory bowel disease: lessons for complex diseases?

Authors:  Daniel R Gaya; Richard K Russell; Elaine R Nimmo; Jack Satsangi
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

2.  Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study.

Authors:  S Björnsson; J H Jóhannsson
Journal:  Eur J Gastroenterol Hepatol       Date:  2000-01       Impact factor: 2.566

Review 3.  Inflammatory bowel disease.

Authors:  Daniel K Podolsky
Journal:  N Engl J Med       Date:  2002-08-08       Impact factor: 91.245

4.  Continuing low incidence of Crohn's disease in Northwest Greece.

Authors:  E V Tsianos; K H Katsanos; D Christodoulou; I Dimoliatis; A Kogevinas; R F Logan
Journal:  Dig Liver Dis       Date:  2003-02       Impact factor: 4.088

5.  Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists.

Authors:  B Moum; M H Vatn; A Ekbom; E Aadland; O Fausa; I Lygren; N Stray; J Sauar; T Schulz
Journal:  Scand J Gastroenterol       Date:  1996-04       Impact factor: 2.423

6.  Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival.

Authors:  E V Loftus; M D Silverstein; W J Sandborn; W J Tremaine; W S Harmsen; A R Zinsmeister
Journal:  Gastroenterology       Date:  1998-06       Impact factor: 22.682

7.  Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD).

Authors:  S Shivananda; J Lennard-Jones; R Logan; N Fear; A Price; L Carpenter; M van Blankenstein
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

8.  Classification of inflammatory bowel disease.

Authors:  J E Lennard-Jones
Journal:  Scand J Gastroenterol Suppl       Date:  1989

9.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

10.  Incidence and prevalence of ulcerative colitis and Crohn's disease in urban and rural areas of Spain from 1981 to 1988.

Authors:  J Maté-Jimenez; S Muñoz; D Vicent; J M Pajares
Journal:  J Clin Gastroenterol       Date:  1994-01       Impact factor: 3.062

View more
  3 in total

1.  State-of-the-art of irritable bowel syndrome and inflammatory bowel disease research in 2008.

Authors:  Lynne V McFarland
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

Review 2.  Rheumatological manifestations in inflammatory bowel disease.

Authors:  Paraskevi V Voulgari
Journal:  Ann Gastroenterol       Date:  2011

3.  ATG16L1 T300A polymorphism is associated with Crohn's disease in a Northwest Greek cohort, but ECM1 T130M and G290S polymorphisms are not associated with ulcerative colitis.

Authors:  Vasileios E Tsianos; Charilaos Kostoulas; Maria Gazouli; Stathis Frillingos; Ioannis Georgiou; Dimitrios K Christodoulou; Konstantinos H Katsanos; Epameinondas V Tsianos
Journal:  Ann Gastroenterol       Date:  2019-11-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.